Oncology
 |
|
28 october 2021 11:20:57 |
| Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling (BMC Cancer) |
|
Tweet Phosphatase and tensin homolog (PTEN) loss is associated with tumorigenesis, tumor progression, and therapy resistance in breast cancer. However, the clinical value of PTEN as a biomarker in these patients is ... |
| 203 viewsCategory: Oncology |
 Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer (BMC Cancer)Homologous recombination proficiency in ovarian and breast cancer patients (BMC Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
